Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SLN | ZVRA |
|---|---|---|
| Price | $9.82 | $11.08 |
| Change today | ▼ 0.10% | ▲ 3.26% |
| Market cap | $610.35M | $657.97M |
| Return, 3 months | -0.4% | -20.5% |
| Return, year to date | +61.5% | +23.7% |
| Return, 1 year | +87.0% | +4.1% |
| P/E (TTM) | -7.6 | 11.9 |
| P/B | 15.9 | 3.0 |
| P/E percentile vs own 5y | 41st | 85th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -100.0% | +53.3% |
| Net profit growth (YoY) | +55.2% | -88.3% |
| Gross margin | 85.9% | 95.5% |
| Operating margin | -11,106.8% | 28.7% |
| Net margin | -9,748.5% | 42.8% |
| Return on equity | -90.4% | 34.8% |
| Analyst target vs. price | +276.8% | +127.9% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 24 | 47 |
| 30-day volatility | 45.1% | 43.9% |
| Max drawdown, 1 year | -41.9% | -35.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
